British High Commission calls for Research Proposals on Ebola
The National Universities Commission (NUC) is in receipt of a call circular from the British High Commission in Nigeria, for research proposals on the Ebola Virus Disease (EVD). The aim of the research is to produce robust research findings that could contribute to the effectiveness of the response to the current outbreak of the disease and to also help draw lessons for future outbreaks of Ebola and other communicable diseases.
The Ebola Health Research Call is being funded by the UK Department for International Development (DFID), the Wellcome Trust and the Enhancing Learning & Research for Humanitarian Assistance (ELRHA), through a special funding window of existing £6.5 million Research for Health in Humanitarian Crises (R2HC) programme.
The size and number of grants to be awarded will depend on the number of high-quality research applications that are within the scope of the Call as a wide range of applications will be considered in terms of the amount of funds requested. Applicants should note that the Call does not cover the funding of laboratory or pathogenesis research.
Scope and eligibility:
Research proposals must aim to strengthen how to improve public health outcomes following Ebola outbreaks. Other relevant research areas include, but not limited to:
1. Anthropology 2. Clinical Management 3. Diagnosis 4. Disease Control and Prevention 5. Ethics 6. Health Systems 7. Social Mobilisation 8. Surveillance 9. Treatment
Kindly note that after the selection of successful research teams in the first stage, they will be invited to develop a more detailed research proposal.
In order to view the Application Instructions, please click here or contact the following e-mail address: email@example.com
Interested qualified researchers are to submit a preliminary Expression of Interest application to ELRHA by 11 Am British Summer Time (Same as Nigeria’s time) on or before 8 September 2014.
Applicants who are unable to meet this deadline should contact ELRHA directly through the email address above.